Last week, members of the German government passed the bill that will enable the country to take its first steps towards reform...
Oxford Cannabinoid Technologies Plc (OCTP), which has been developing cannabinoid-based medicines since 2017, announced this week that it is expanding its research and...
Ukrainian deputies have approved the first reading of a plan to legalize cannabis for medical purposes. Officials voted in favor of the adoption of the...
In a statement issued on Friday June 23, a group of United Nations representatives and human rights experts called for an end to...
At the end of last week, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) published its annual report on drugs in Europe, which gives an...
An anonymous survey conducted by the Irish Medical Times (IMT) has revealed that more than half (54%) of doctors are in favor of decriminalizing small-scale...
A four-year pilot project, which would authorize the use of cannabis for medical purposes in Iceland, has been proposed by the country's politicians....
A major clinical trial examining the role of the cannabis-based drug Sativex in the treatment of the most aggressive brain tumors has enrolled...
A new study concludes there is no significant link between cannabis consumption and the onset of psychosis, which contrasts with some earlier data and...
Greek patients hope to finally have access to legal cannabis-based medicines in 2023, six years after the law was first amended....
The first scientific study to examine the phenomenon of cannabis-induced «hangover» found little evidence of impairment...
A new report offers an encouraging picture of the current and future CBD landscape in Europe. Let's explore how, when and why (or why not) people...
